These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8611718)

  • 1. Routine bone marrow exam during first remission of acute myeloid leukemia.
    Estey E; Pierce S
    Blood; 1996 May; 87(9):3899-902. PubMed ID: 8611718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine bone marrow punctures during remission of acute myelogenous leukemia.
    Müller E; Sauter C
    Leukemia; 1992 May; 6(5):419. PubMed ID: 1593905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
    Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
    J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
    Chen X; Xie H; Wood BL; Walter RB; Pagel JM; Becker PS; Sandhu VK; Abkowitz JL; Appelbaum FR; Estey EH
    J Clin Oncol; 2015 Apr; 33(11):1258-64. PubMed ID: 25732155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
    Vogler WR; Raney MR
    Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of interleukin-6 in patients with smoldering relapse of acute myelogenous leukemia.
    Estey E; Andreeff M
    Leukemia; 1995 Sep; 9(9):1440-3. PubMed ID: 7658709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia.
    Percival ME; Lai C; Estey E; Hourigan CS
    Blood Rev; 2017 Jul; 31(4):185-192. PubMed ID: 28190619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
    Tavernier E; Le QH; Elhamri M; Thomas X
    Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow transplantation in relapsed adult acute leukemia.
    Dicke KA; Zander AR; Spitzer G; Verma DS; Peters LJ; Vellekoop L; Thomson S; Stewart D; Hester JP; McCredie KB
    Exp Hematol; 1979; 7 Suppl 5():170-87. PubMed ID: 400685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes.
    Hirst WJ; Mufti GJ
    Leuk Res; 1994 Nov; 18(11):797-804. PubMed ID: 7967705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proportion of CD34(+)CD38(-) cell population in bone marrow of patients with de novo AML as prognostic factor of complete remission at first course of induction chemotherapy].
    Zhang CP; Wei H; Wang HJ; Huai L; He K; Chen YR; Lin D; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1268-72. PubMed ID: 22040986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustered precursors in bone marrow sections predict early relapse in patients with acute myeloid leukemia within hematologic remission.
    Yu Y; Wu Z; Zhang J; Zhai Y; Yuan Y; Liu S; Wang H; Shi J
    J Transl Med; 2014 Jan; 12():18. PubMed ID: 24447607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
    Dick FR; Burns CP; Weiner GJ; Heckman KD
    Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.
    Freireich EJ; Cork A; Stass SA; McCredie KB; Keating MJ; Estey EH; Kantarjian HM; Trujillo JM
    Leukemia; 1992 Jun; 6(6):500-6. PubMed ID: 1602788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
    Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse.
    Rosenfeld C; Shadduck RK; Przepiorka D; Mangan KF; Colvin M
    Blood; 1989 Aug; 74(3):1159-64. PubMed ID: 2665865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations.
    Koschade SE; Stratmann JA; Finkelmeier F; Wagner S; Chromik J; Steffen B; Serve H; Brandts CH; Ballo O
    Ann Hematol; 2022 Aug; 101(8):1703-1710. PubMed ID: 35595925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.